Loading clinical trials...
Loading clinical trials...
Proteomic and Transcriptomic Biomarkers of Circadian Timing - Validation of Circadian Biomarkers in Patients With Sleep Disorders
Conditions
Interventions
dim light melatonin onset (DLMO)
Locations
1
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
November 2, 2021
Primary Completion Date
June 30, 2024
Completion Date
July 1, 2024
Last Updated
August 6, 2024
NCT07440147
NCT06288568
NCT04966351
NCT06129942
NCT06473415
NCT05309577
Lead Sponsor
Brigham and Women's Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions